GlassScriptPhysician profile
Chase Garland Corvin
NPI 1174059422
$3,269.91
in general payments reported to CMS, 2019-2025
8 companies · $1,485 in 2025
The $1,485 reported for 2025 was more than what 77% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $305 · 2021: $1,332 · 2024: $149 · 2025: $1,485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,000 · Food and Beverage: $545 · Travel and Lodging: $88.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,000.00 |
| Food and Beverage | $544.66 |
| Travel and Lodging | $88.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,028.00 | 2021-2025 | |
| Medical Device Business Services, INC. | $766.85 | 2020-2025 | Echelon Flex |
| Abiomed | $326.10 | 2024-2025 | Impella |
| Artivion, INC. | $39.69 | 2025 | Amds-Ascyrus Medical, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Baxter Healthcare | $30.00 | 2025 | Ostene, Coseal, Adept |
| Abbott Laboratories | $29.65 | 2025 | Epic |
| Heron Therapeutics, INC. | $26.67 | 2021 | |
| Ethicon US, LLC | $22.95 | 2025 | Echelon Flex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chase Corvin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.